A detailed history of Voya Investment Management LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 31,530 shares of STRO stock, worth $59,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,530
Previous 27,966 12.74%
Holding current value
$59,276
Previous $81,000 34.57%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.88 - $5.01 $10,264 - $17,855
3,564 Added 12.74%
31,530 $109,000
Q2 2024

Dec 03, 2024

SELL
$2.92 - $5.33 $10,406 - $18,996
-3,564 Reduced 11.3%
27,966 $81,000
Q2 2024

Aug 14, 2024

BUY
$2.92 - $5.33 $23,100 - $42,165
7,911 Added 39.45%
27,966 $81,000
Q1 2024

Dec 06, 2024

SELL
$3.27 - $5.65 $37,523 - $64,833
-11,475 Reduced 36.39%
20,055 $113,000
Q1 2024

May 15, 2024

SELL
$3.27 - $5.65 $19,508 - $33,707
-5,966 Reduced 22.93%
20,055 $113,000
Q4 2023

Feb 14, 2024

BUY
$2.07 - $4.54 $2,732 - $5,992
1,320 Added 5.34%
26,021 $111,000
Q2 2023

Aug 14, 2023

BUY
$4.25 - $5.88 $20,157 - $27,888
4,743 Added 23.76%
24,701 $114,000
Q3 2022

Nov 14, 2022

BUY
$5.17 - $7.11 $14,724 - $20,249
2,848 Added 16.65%
19,958 $111,000
Q4 2021

Feb 14, 2022

BUY
$14.25 - $23.53 $1,824 - $3,011
128 Added 0.75%
17,110 $255,000
Q2 2021

Aug 16, 2021

BUY
$18.03 - $23.82 $60,707 - $80,201
3,367 Added 24.73%
16,982 $316,000
Q1 2021

May 17, 2021

BUY
$20.29 - $27.54 $37,637 - $51,086
1,855 Added 15.77%
13,615 $310,000
Q4 2020

Feb 16, 2021

BUY
$10.16 - $23.98 $119,481 - $282,004
11,760 New
11,760 $255,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $98.1M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.